Stay updated on Avelumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Avelumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - Added a prominent operations status notice about funding and service limitations, and linked official status pages. - Updated version from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-06T06:00:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-29T03:14:18.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' navigation element was removed.
    Difference
    0.6%
    Check dated 2025-09-14T21:21:57.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-09-07T17:09:36.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    30%
    Check dated 2025-08-31T12:17:43.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:38:49.000Z thumbnail image

Stay in the know with updates to Avelumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in NSCLC Clinical Trial page.